Nukkleus Inc

Nukkleus Inc (NASDAQ: NUKK) is a financial technology firm specializing in delivering software and technology solutions to the global retail foreign exchange (FX) trading sector. Its core offerings include a comprehensive package of software, technology infrastructure, customer sales and marketing services, as well as risk management tools, which it primarily supplies to Triton Capital Markets Ltd.

Positive Growth Aspects

• Significant Improvement in Net Income: One of the most notable positive developments is the company’s dramatic turnaround in profitability. For the three months ended March 31, 2025, the company generated a pre-tax net income of approximately USD 103.1 million, a stark contrast to the USD 2.1 million pre-tax net loss reported in the same period of 2024. This substantial improvement was primarily due to a USD 104.3 million gain from the change in fair value of stock purchase warrant liabilities, along with a USD 567,000 gain from the change in fair value of a convertible note embedded derivative. While these are non-operating items, they significantly strengthened the company’s bottom line.
• Reduction in Professional Fees: Professional fees decreased by approximately USD 878,000 (47.9%) compared to Q1 2024. This reduction was largely due to a one-time spike in advisory and legal fees in early 2024, which were related to a prior business combination. The decrease was driven by a USD 1.17 million drop in advisory service fees and a USD 222,000 reduction in legal fees, despite a moderate rise in consulting and audit fees. This reflects better cost control and reduced one-time expenditures, enhancing the efficiency of operating expenses in the short term.
• Reduced Losses from Discontinued Operations: Net loss from discontinued operations declined from USD 334,216 in Q1 2024 to USD 182,755 in Q1 2025. The reduction reflects improvements in the performance of the company’s discontinued subsidiary, DRFQ. This trend is favorable as it reduces the financial drag from non-core operations and indicates the company's strategic efforts to streamline or wind down unprofitable segments are working.
• Improved Capital Structure and Accumulated Deficit Reduction: The company also showed signs of improving its capital structure. The accumulated deficit decreased significantly from USD 201.1 million as of December 31, 2024, to USD 98.1 million by March 31, 2025, reflecting the net income impact during the quarter. This reduction signals a stronger balance sheet and improved shareholder equity, which can be important for future fundraising or investor confidence.

Growth Challenges

• Operating Cash Flow Still in the Negative: Despite the surge in net income, the company’s operating activities consumed USD 1.34 million in cash during Q1 2025, up from USD 1.12 million in Q1 2024. The disconnect between reported net income and cash flow from operations is mainly due to significant non-cash gains such as the warrant liability fair value adjustment. This indicates that profitability is not yet translating into sustainable cash generation from core operations, raising concerns about the quality and stability of earnings.
• Rising Administrative and Compensation Expenses: Other general and administrative expenses increased by 119.1% year-over-year. Key drivers included public company costs like D&O insurance, marketing, and new rent expenses related to new offices in Israel and New York. Additionally, compensation and benefits doubled, reflecting new consultancy agreements and potentially pending acquisitions. These rising expenses may be a burden on the company's limited cash resources if revenue growth does not keep pace.
• Weak Liquidity and Working Capital Deficit: The company continues to face liquidity challenges. As of March 31, 2025, it had only USD 4.46 million in cash and a working capital deficit of USD 56.25 million, indicating that current liabilities far exceed current assets. The company acknowledges it has not been able to generate sufficient operating cash flow to fund its operations and may need to raise more capital. This situation casts substantial doubt on the company’s ability to continue as a going concern, especially without a clear path to consistent operational profitability or new financing.
• Dependence on Future Financing and Risk of Dilution: Given its current cash position and expected increases in operating costs (e.g., executive consultants and acquisition-related integration), the company may need to raise additional equity or debt capital in the near term. However, new equity financing could dilute existing shareholders, while debt financing might come with high interest costs or restrictive covenants. Either route could impact the company’s strategic flexibility and long-term shareholder value.

Technical Observation (on the daily chart):

NUKK has been consolidating between USD 12 and USD 18 since its sharp spike and subsequent decline in late December 2024. The stock is currently trading below both its 21-day and 50-day moving averages, signaling short-term bearish momentum. RSI sits at a neutral 44.5, indicating no overbought or oversold conditions, while low trading volume suggests waning investor interest.

The company’s Q1 2025 performance presents a mixed picture. On the positive side, it reported a significant net income of over USD 103 million—primarily driven by non-cash gains from warrant and derivative revaluations—and reduced its accumulated deficit substantially. It also lowered professional fees year-over-year and narrowed losses from discontinued operations. However, these improvements are overshadowed by underlying weaknesses, including negative operating cash flow, rising administrative and compensation costs, a substantial working capital deficit, and ongoing liquidity concerns. With limited cash reserves and increasing reliance on external financing, the company’s short-term financial health remains fragile despite encouraging headline profitability. 

As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Watch’ rating has been given to Nukkleus Inc (NASDAQ: NUKK) at the closing market price of USD 14.25 as of Jun 03,2025. 

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is June 03,2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.